1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECHNOLOGY
  4. BIOCON LTD.
Biocon Ltd.
NSE: BIOCON | BSE: 532523
Mid-range Performer
Download real time
Clinical Trials Patent Approvals
Ask MarketMind AI
418.40 0.90 (0.22%)
1.8M
NSE+BSE Volume

NSE 27 Aug, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert
Regulatory Approval
Biocon's arm gets Japan MHLW nod for pegfilgrastim injection, targeting a $210.3 million market See details

Biocon - BIOCON - stock price prediction, stock forecast, target price, analyst ratings from 19 analysts

Biocon has a share price target of Rs 439, revenue growth forecast of 14.6%, and profit growth estimate of 181.6% for FY27, based on top 19 analyst calls.

Forecaster Screeners